BioRestorative Therapies, Inc. Share Price Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 37.71L 32.43L 30.5L 27.84L 52.07L 36Cr 52.24L 3.62Cr 1.4Cr 18Cr 1.42Cr 1.39Cr 58Cr | P/E 2026 * |
-0.01x | P/E 2027 * | -0.02x |
|---|---|---|---|---|---|
| Enterprise Value | 37.71L 32.43L 30.5L 27.84L 52.07L 36Cr 52.24L 3.62Cr 1.4Cr 18Cr 1.42Cr 1.39Cr 58Cr | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 1.63x |
| Free-Float |
98.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 27/08/2026 |
Anna Skowron
DFI | Director of Finance/CFO | 38 | 27/08/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
Jay Dhaliwal
BRD | Director/Board Member | 37 | 12/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 13/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 37.71L | |
| -0.38% | -0.99% | +42.69% | +100.85% | 6.78TCr | |
| -0.41% | -2.30% | +33.53% | +78.63% | 6.32TCr | |
| -0.31% | +3.67% | -12.96% | +374.95% | 2.76TCr | |
| +0.86% | +2.12% | -7.74% | -13.34% | 2.61TCr | |
| +1.69% | -0.36% | +26.48% | +15.46% | 2.54TCr | |
| +1.38% | +0.75% | +24.38% | -17.91% | 1.99TCr | |
| +1.15% | -5.02% | +219.82% | +379.02% | 1.74TCr | |
| -0.49% | -0.37% | -7.31% | +524.84% | 1.5TCr | |
| -0.20% | +8.00% | +55.78% | +167.98% | 1.46TCr | |
| Average | +0.58% | +1.67% | +41.63% | +178.94% | 3.08TCr | |
| Weighted average by Cap. | +0.23% | +0.90% | +36.63% | +139.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.05L 12.08L 11.36L 10.37L 19.4L 13Cr 19.46L 1.35Cr 52.08L 6.8Cr 52.76L 51.61L 22Cr | 23.12L 19.89L 18.7L 17.07L 31.93L 22Cr 32.04L 2.22Cr 85.73L 11Cr 86.84L 84.95L 36Cr |
| Net income | -1.35Cr -1.16Cr -1.09Cr -99.85L -1.87Cr -127.9Cr -1.87Cr -13Cr -5.01Cr -65Cr -5.08Cr -4.97Cr -208.62Cr | -1.56Cr -1.34Cr -1.26Cr -1.15Cr -2.15Cr -147.14Cr -2.16Cr -15Cr -5.77Cr -75Cr -5.84Cr -5.72Cr -240.02Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
